Jiang Z, Zhou A, Sun Y, Zhang W, et al. Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study. BMC Cancer 2022;22:253.
PMID: 35264150